Global Molecular Pathology Services Supply, Demand and Key Producers, 2026-2032
The global Molecular Pathology Services market size is expected to reach $ 279 million by 2032, rising at a market growth of 7.4% CAGR during the forecast period (2026-2032).
Molecular Pathology Services refer to laboratory and consultative pathology services that use DNA-, RNA-, and biomarker-based testing methods to support disease diagnosis, classification, prognosis, therapy selection, and treatment monitoring. These services commonly integrate PCR, NGS, FISH, sequencing, liquid biopsy, pathology interpretation, and clinical reporting into a unified diagnostic workflow.
This report studies the global Molecular Pathology Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Molecular Pathology Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Molecular Pathology Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Molecular Pathology Services total market, 2021-2032, (USD Million)
Global Molecular Pathology Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Molecular Pathology Services total market, key domestic companies, and share, (USD Million)
Global Molecular Pathology Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global Molecular Pathology Services total market by Type, CAGR, 2021-2032, (USD Million)
Global Molecular Pathology Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Molecular Pathology Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Quest Diagnostics, Labcorp, Sonic Healthcare, NeoGenomics, Foundation Medicine, Caris Life Sciences, Tempus, Guardant Health, Exact Sciences, Eurofins, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Molecular Pathology Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Molecular Pathology Services Market, By Region:
1. How big is the global Molecular Pathology Services market?
2. What is the demand of the global Molecular Pathology Services market?
3. What is the year over year growth of the global Molecular Pathology Services market?
4. What is the total value of the global Molecular Pathology Services market?
5. Who are the Major Players in the global Molecular Pathology Services market?
6. What are the growth factors driving the market demand?
Molecular Pathology Services refer to laboratory and consultative pathology services that use DNA-, RNA-, and biomarker-based testing methods to support disease diagnosis, classification, prognosis, therapy selection, and treatment monitoring. These services commonly integrate PCR, NGS, FISH, sequencing, liquid biopsy, pathology interpretation, and clinical reporting into a unified diagnostic workflow.
This report studies the global Molecular Pathology Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Molecular Pathology Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Molecular Pathology Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Molecular Pathology Services total market, 2021-2032, (USD Million)
Global Molecular Pathology Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Molecular Pathology Services total market, key domestic companies, and share, (USD Million)
Global Molecular Pathology Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global Molecular Pathology Services total market by Type, CAGR, 2021-2032, (USD Million)
Global Molecular Pathology Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Molecular Pathology Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Quest Diagnostics, Labcorp, Sonic Healthcare, NeoGenomics, Foundation Medicine, Caris Life Sciences, Tempus, Guardant Health, Exact Sciences, Eurofins, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Molecular Pathology Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Molecular Pathology Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Solid Tumor Molecular Pathology Services
- Hematologic Malignancy Molecular Pathology Services
- Hereditary Disease Molecular Pathology Services
- Infectious Disease Molecular Testing Services
- Rare Disease Molecular Pathology Services
- Others
- Single-Gene Testing Services
- Targeted Panel Testing Services
- Comprehensive Genomic Profiling Services
- Companion Diagnostic Support Services
- Pathology Consultation and Interpretation Services
- Others
- Hospitals and Medical Centers
- Independent Clinical Laboratories
- Academic and Research Institutes
- Biopharmaceutical Companies
- Others
- Quest Diagnostics
- Labcorp
- Sonic Healthcare
- NeoGenomics
- Foundation Medicine
- Caris Life Sciences
- Tempus
- Guardant Health
- Exact Sciences
- Eurofins
- Unilabs
1. How big is the global Molecular Pathology Services market?
2. What is the demand of the global Molecular Pathology Services market?
3. What is the year over year growth of the global Molecular Pathology Services market?
4. What is the total value of the global Molecular Pathology Services market?
5. Who are the Major Players in the global Molecular Pathology Services market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Molecular Pathology Services Introduction
1.2 World Molecular Pathology Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Molecular Pathology Services Total Market by Region (by Headquarter Location)
1.3.1 World Molecular Pathology Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Molecular Pathology Services Revenue (2021-2032)
1.3.3 China Based Company Molecular Pathology Services Revenue (2021-2032)
1.3.4 Europe Based Company Molecular Pathology Services Revenue (2021-2032)
1.3.5 Japan Based Company Molecular Pathology Services Revenue (2021-2032)
1.3.6 South Korea Based Company Molecular Pathology Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Molecular Pathology Services Revenue (2021-2032)
1.3.8 India Based Company Molecular Pathology Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Molecular Pathology Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Molecular Pathology Services Consumption Value (2021-2032)
2.2 World Molecular Pathology Services Consumption Value by Region
2.2.1 World Molecular Pathology Services Consumption Value by Region (2021-2026)
2.2.2 World Molecular Pathology Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Molecular Pathology Services Consumption Value (2021-2032)
2.4 China Molecular Pathology Services Consumption Value (2021-2032)
2.5 Europe Molecular Pathology Services Consumption Value (2021-2032)
2.6 Japan Molecular Pathology Services Consumption Value (2021-2032)
2.7 South Korea Molecular Pathology Services Consumption Value (2021-2032)
2.8 ASEAN Molecular Pathology Services Consumption Value (2021-2032)
2.9 India Molecular Pathology Services Consumption Value (2021-2032)
3 WORLD MOLECULAR PATHOLOGY SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Molecular Pathology Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Molecular Pathology Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Molecular Pathology Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Molecular Pathology Services in 2025
3.3 Molecular Pathology Services Company Evaluation Quadrant
3.4 Molecular Pathology Services Market: Overall Company Footprint Analysis
3.4.1 Molecular Pathology Services Market: Region Footprint
3.4.2 Molecular Pathology Services Market: Company Product Type Footprint
3.4.3 Molecular Pathology Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Molecular Pathology Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Molecular Pathology Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Molecular Pathology Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Molecular Pathology Services Consumption Value Comparison
4.2.1 United States VS China: Molecular Pathology Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Molecular Pathology Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Molecular Pathology Services Companies and Market Share, 2021-2026
4.3.1 United States Based Molecular Pathology Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Molecular Pathology Services Revenue, (2021-2026)
4.4 China Based Companies Molecular Pathology Services Revenue and Market Share, 2021-2026
4.4.1 China Based Molecular Pathology Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Molecular Pathology Services Revenue, (2021-2026)
4.5 Rest of World Based Molecular Pathology Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Molecular Pathology Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Molecular Pathology Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Molecular Pathology Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Solid Tumor Molecular Pathology Services
5.2.2 Hematologic Malignancy Molecular Pathology Services
5.2.3 Hereditary Disease Molecular Pathology Services
5.2.4 Infectious Disease Molecular Testing Services
5.2.5 Rare Disease Molecular Pathology Services
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Molecular Pathology Services Market Size by Type (2021-2026)
5.3.2 World Molecular Pathology Services Market Size by Type (2027-2032)
5.3.3 World Molecular Pathology Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SERVICE CONTENT
6.1 World Molecular Pathology Services Market Size Overview by Service Content: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Service Content
6.2.1 Single-Gene Testing Services
6.2.2 Targeted Panel Testing Services
6.2.3 Comprehensive Genomic Profiling Services
6.2.4 Companion Diagnostic Support Services
6.2.5 Pathology Consultation and Interpretation Services
6.2.6 Others
6.3 Market Segment by Service Content
6.3.1 World Molecular Pathology Services Market Size by Service Content (2021-2026)
6.3.2 World Molecular Pathology Services Market Size by Service Content (2027-2032)
6.3.3 World Molecular Pathology Services Market Size Market Share by Service Content (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Molecular Pathology Services Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospitals and Medical Centers
7.2.2 Independent Clinical Laboratories
7.2.3 Academic and Research Institutes
7.2.4 Biopharmaceutical Companies
7.2.5 Others
7.3 Market Segment by Application
7.3.1 World Molecular Pathology Services Market Size by Application (2021-2026)
7.3.2 World Molecular Pathology Services Market Size by Application (2027-2032)
7.3.3 World Molecular Pathology Services Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 Quest Diagnostics
8.1.1 Quest Diagnostics Details
8.1.2 Quest Diagnostics Major Business
8.1.3 Quest Diagnostics Molecular Pathology Services Product and Services
8.1.4 Quest Diagnostics Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 Quest Diagnostics Recent Developments/Updates
8.1.6 Quest Diagnostics Competitive Strengths & Weaknesses
8.2 Labcorp
8.2.1 Labcorp Details
8.2.2 Labcorp Major Business
8.2.3 Labcorp Molecular Pathology Services Product and Services
8.2.4 Labcorp Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Labcorp Recent Developments/Updates
8.2.6 Labcorp Competitive Strengths & Weaknesses
8.3 Sonic Healthcare
8.3.1 Sonic Healthcare Details
8.3.2 Sonic Healthcare Major Business
8.3.3 Sonic Healthcare Molecular Pathology Services Product and Services
8.3.4 Sonic Healthcare Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 Sonic Healthcare Recent Developments/Updates
8.3.6 Sonic Healthcare Competitive Strengths & Weaknesses
8.4 NeoGenomics
8.4.1 NeoGenomics Details
8.4.2 NeoGenomics Major Business
8.4.3 NeoGenomics Molecular Pathology Services Product and Services
8.4.4 NeoGenomics Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 NeoGenomics Recent Developments/Updates
8.4.6 NeoGenomics Competitive Strengths & Weaknesses
8.5 Foundation Medicine
8.5.1 Foundation Medicine Details
8.5.2 Foundation Medicine Major Business
8.5.3 Foundation Medicine Molecular Pathology Services Product and Services
8.5.4 Foundation Medicine Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Foundation Medicine Recent Developments/Updates
8.5.6 Foundation Medicine Competitive Strengths & Weaknesses
8.6 Caris Life Sciences
8.6.1 Caris Life Sciences Details
8.6.2 Caris Life Sciences Major Business
8.6.3 Caris Life Sciences Molecular Pathology Services Product and Services
8.6.4 Caris Life Sciences Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Caris Life Sciences Recent Developments/Updates
8.6.6 Caris Life Sciences Competitive Strengths & Weaknesses
8.7 Tempus
8.7.1 Tempus Details
8.7.2 Tempus Major Business
8.7.3 Tempus Molecular Pathology Services Product and Services
8.7.4 Tempus Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Tempus Recent Developments/Updates
8.7.6 Tempus Competitive Strengths & Weaknesses
8.8 Guardant Health
8.8.1 Guardant Health Details
8.8.2 Guardant Health Major Business
8.8.3 Guardant Health Molecular Pathology Services Product and Services
8.8.4 Guardant Health Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Guardant Health Recent Developments/Updates
8.8.6 Guardant Health Competitive Strengths & Weaknesses
8.9 Exact Sciences
8.9.1 Exact Sciences Details
8.9.2 Exact Sciences Major Business
8.9.3 Exact Sciences Molecular Pathology Services Product and Services
8.9.4 Exact Sciences Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 Exact Sciences Recent Developments/Updates
8.9.6 Exact Sciences Competitive Strengths & Weaknesses
8.10 Eurofins
8.10.1 Eurofins Details
8.10.2 Eurofins Major Business
8.10.3 Eurofins Molecular Pathology Services Product and Services
8.10.4 Eurofins Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Eurofins Recent Developments/Updates
8.10.6 Eurofins Competitive Strengths & Weaknesses
8.11 Unilabs
8.11.1 Unilabs Details
8.11.2 Unilabs Major Business
8.11.3 Unilabs Molecular Pathology Services Product and Services
8.11.4 Unilabs Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 Unilabs Recent Developments/Updates
8.11.6 Unilabs Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Molecular Pathology Services Industry Chain
9.2 Molecular Pathology Services Upstream Analysis
9.3 Molecular Pathology Services Midstream Analysis
9.4 Molecular Pathology Services Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Molecular Pathology Services Introduction
1.2 World Molecular Pathology Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Molecular Pathology Services Total Market by Region (by Headquarter Location)
1.3.1 World Molecular Pathology Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Molecular Pathology Services Revenue (2021-2032)
1.3.3 China Based Company Molecular Pathology Services Revenue (2021-2032)
1.3.4 Europe Based Company Molecular Pathology Services Revenue (2021-2032)
1.3.5 Japan Based Company Molecular Pathology Services Revenue (2021-2032)
1.3.6 South Korea Based Company Molecular Pathology Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Molecular Pathology Services Revenue (2021-2032)
1.3.8 India Based Company Molecular Pathology Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Molecular Pathology Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Molecular Pathology Services Consumption Value (2021-2032)
2.2 World Molecular Pathology Services Consumption Value by Region
2.2.1 World Molecular Pathology Services Consumption Value by Region (2021-2026)
2.2.2 World Molecular Pathology Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Molecular Pathology Services Consumption Value (2021-2032)
2.4 China Molecular Pathology Services Consumption Value (2021-2032)
2.5 Europe Molecular Pathology Services Consumption Value (2021-2032)
2.6 Japan Molecular Pathology Services Consumption Value (2021-2032)
2.7 South Korea Molecular Pathology Services Consumption Value (2021-2032)
2.8 ASEAN Molecular Pathology Services Consumption Value (2021-2032)
2.9 India Molecular Pathology Services Consumption Value (2021-2032)
3 WORLD MOLECULAR PATHOLOGY SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Molecular Pathology Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Molecular Pathology Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Molecular Pathology Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Molecular Pathology Services in 2025
3.3 Molecular Pathology Services Company Evaluation Quadrant
3.4 Molecular Pathology Services Market: Overall Company Footprint Analysis
3.4.1 Molecular Pathology Services Market: Region Footprint
3.4.2 Molecular Pathology Services Market: Company Product Type Footprint
3.4.3 Molecular Pathology Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Molecular Pathology Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Molecular Pathology Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Molecular Pathology Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Molecular Pathology Services Consumption Value Comparison
4.2.1 United States VS China: Molecular Pathology Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Molecular Pathology Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Molecular Pathology Services Companies and Market Share, 2021-2026
4.3.1 United States Based Molecular Pathology Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Molecular Pathology Services Revenue, (2021-2026)
4.4 China Based Companies Molecular Pathology Services Revenue and Market Share, 2021-2026
4.4.1 China Based Molecular Pathology Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Molecular Pathology Services Revenue, (2021-2026)
4.5 Rest of World Based Molecular Pathology Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Molecular Pathology Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Molecular Pathology Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Molecular Pathology Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Solid Tumor Molecular Pathology Services
5.2.2 Hematologic Malignancy Molecular Pathology Services
5.2.3 Hereditary Disease Molecular Pathology Services
5.2.4 Infectious Disease Molecular Testing Services
5.2.5 Rare Disease Molecular Pathology Services
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Molecular Pathology Services Market Size by Type (2021-2026)
5.3.2 World Molecular Pathology Services Market Size by Type (2027-2032)
5.3.3 World Molecular Pathology Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SERVICE CONTENT
6.1 World Molecular Pathology Services Market Size Overview by Service Content: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Service Content
6.2.1 Single-Gene Testing Services
6.2.2 Targeted Panel Testing Services
6.2.3 Comprehensive Genomic Profiling Services
6.2.4 Companion Diagnostic Support Services
6.2.5 Pathology Consultation and Interpretation Services
6.2.6 Others
6.3 Market Segment by Service Content
6.3.1 World Molecular Pathology Services Market Size by Service Content (2021-2026)
6.3.2 World Molecular Pathology Services Market Size by Service Content (2027-2032)
6.3.3 World Molecular Pathology Services Market Size Market Share by Service Content (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Molecular Pathology Services Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospitals and Medical Centers
7.2.2 Independent Clinical Laboratories
7.2.3 Academic and Research Institutes
7.2.4 Biopharmaceutical Companies
7.2.5 Others
7.3 Market Segment by Application
7.3.1 World Molecular Pathology Services Market Size by Application (2021-2026)
7.3.2 World Molecular Pathology Services Market Size by Application (2027-2032)
7.3.3 World Molecular Pathology Services Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 Quest Diagnostics
8.1.1 Quest Diagnostics Details
8.1.2 Quest Diagnostics Major Business
8.1.3 Quest Diagnostics Molecular Pathology Services Product and Services
8.1.4 Quest Diagnostics Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 Quest Diagnostics Recent Developments/Updates
8.1.6 Quest Diagnostics Competitive Strengths & Weaknesses
8.2 Labcorp
8.2.1 Labcorp Details
8.2.2 Labcorp Major Business
8.2.3 Labcorp Molecular Pathology Services Product and Services
8.2.4 Labcorp Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Labcorp Recent Developments/Updates
8.2.6 Labcorp Competitive Strengths & Weaknesses
8.3 Sonic Healthcare
8.3.1 Sonic Healthcare Details
8.3.2 Sonic Healthcare Major Business
8.3.3 Sonic Healthcare Molecular Pathology Services Product and Services
8.3.4 Sonic Healthcare Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 Sonic Healthcare Recent Developments/Updates
8.3.6 Sonic Healthcare Competitive Strengths & Weaknesses
8.4 NeoGenomics
8.4.1 NeoGenomics Details
8.4.2 NeoGenomics Major Business
8.4.3 NeoGenomics Molecular Pathology Services Product and Services
8.4.4 NeoGenomics Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 NeoGenomics Recent Developments/Updates
8.4.6 NeoGenomics Competitive Strengths & Weaknesses
8.5 Foundation Medicine
8.5.1 Foundation Medicine Details
8.5.2 Foundation Medicine Major Business
8.5.3 Foundation Medicine Molecular Pathology Services Product and Services
8.5.4 Foundation Medicine Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Foundation Medicine Recent Developments/Updates
8.5.6 Foundation Medicine Competitive Strengths & Weaknesses
8.6 Caris Life Sciences
8.6.1 Caris Life Sciences Details
8.6.2 Caris Life Sciences Major Business
8.6.3 Caris Life Sciences Molecular Pathology Services Product and Services
8.6.4 Caris Life Sciences Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Caris Life Sciences Recent Developments/Updates
8.6.6 Caris Life Sciences Competitive Strengths & Weaknesses
8.7 Tempus
8.7.1 Tempus Details
8.7.2 Tempus Major Business
8.7.3 Tempus Molecular Pathology Services Product and Services
8.7.4 Tempus Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Tempus Recent Developments/Updates
8.7.6 Tempus Competitive Strengths & Weaknesses
8.8 Guardant Health
8.8.1 Guardant Health Details
8.8.2 Guardant Health Major Business
8.8.3 Guardant Health Molecular Pathology Services Product and Services
8.8.4 Guardant Health Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Guardant Health Recent Developments/Updates
8.8.6 Guardant Health Competitive Strengths & Weaknesses
8.9 Exact Sciences
8.9.1 Exact Sciences Details
8.9.2 Exact Sciences Major Business
8.9.3 Exact Sciences Molecular Pathology Services Product and Services
8.9.4 Exact Sciences Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 Exact Sciences Recent Developments/Updates
8.9.6 Exact Sciences Competitive Strengths & Weaknesses
8.10 Eurofins
8.10.1 Eurofins Details
8.10.2 Eurofins Major Business
8.10.3 Eurofins Molecular Pathology Services Product and Services
8.10.4 Eurofins Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Eurofins Recent Developments/Updates
8.10.6 Eurofins Competitive Strengths & Weaknesses
8.11 Unilabs
8.11.1 Unilabs Details
8.11.2 Unilabs Major Business
8.11.3 Unilabs Molecular Pathology Services Product and Services
8.11.4 Unilabs Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 Unilabs Recent Developments/Updates
8.11.6 Unilabs Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Molecular Pathology Services Industry Chain
9.2 Molecular Pathology Services Upstream Analysis
9.3 Molecular Pathology Services Midstream Analysis
9.4 Molecular Pathology Services Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Molecular Pathology Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Molecular Pathology Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Molecular Pathology Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Molecular Pathology Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Molecular Pathology Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Molecular Pathology Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Molecular Pathology Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Molecular Pathology Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Molecular Pathology Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Molecular Pathology Services Players in 2025
Table 12. World Molecular Pathology Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Molecular Pathology Services Company Evaluation Quadrant
Table 14. Head Office of Key Molecular Pathology Services Players
Table 15. Molecular Pathology Services Market: Company Product Type Footprint
Table 16. Molecular Pathology Services Market: Company Product Application Footprint
Table 17. Molecular Pathology Services Mergers & Acquisitions Activity
Table 18. United States VS China Molecular Pathology Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Molecular Pathology Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Molecular Pathology Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Molecular Pathology Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Molecular Pathology Services Revenue Market Share (2021-2026)
Table 23. China Based Molecular Pathology Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Molecular Pathology Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Molecular Pathology Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Molecular Pathology Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Molecular Pathology Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Molecular Pathology Services Revenue Market Share (2021-2026)
Table 29. World Molecular Pathology Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Molecular Pathology Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Molecular Pathology Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Molecular Pathology Services Market Size by Service Content, (USD Million), 2021 & 2025 & 2032
Table 33. World Molecular Pathology Services Market Size Value by Service Content (2021-2026) & (USD Million)
Table 34. World Molecular Pathology Services Market Size by Service Content (2027-2032) & (USD Million)
Table 35. World Molecular Pathology Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Molecular Pathology Services Market Size by Application (2021-2026) & (USD Million)
Table 37. World Molecular Pathology Services Market Size by Application (2027-2032) & (USD Million)
Table 38. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 39. Quest Diagnostics Major Business
Table 40. Quest Diagnostics Molecular Pathology Services Product and Services
Table 41. Quest Diagnostics Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Quest Diagnostics Recent Developments/Updates
Table 43. Quest Diagnostics Competitive Strengths & Weaknesses
Table 44. Labcorp Basic Information, Manufacturing Base and Competitors
Table 45. Labcorp Major Business
Table 46. Labcorp Molecular Pathology Services Product and Services
Table 47. Labcorp Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Labcorp Recent Developments/Updates
Table 49. Labcorp Competitive Strengths & Weaknesses
Table 50. Sonic Healthcare Basic Information, Manufacturing Base and Competitors
Table 51. Sonic Healthcare Major Business
Table 52. Sonic Healthcare Molecular Pathology Services Product and Services
Table 53. Sonic Healthcare Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Sonic Healthcare Recent Developments/Updates
Table 55. Sonic Healthcare Competitive Strengths & Weaknesses
Table 56. NeoGenomics Basic Information, Manufacturing Base and Competitors
Table 57. NeoGenomics Major Business
Table 58. NeoGenomics Molecular Pathology Services Product and Services
Table 59. NeoGenomics Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. NeoGenomics Recent Developments/Updates
Table 61. NeoGenomics Competitive Strengths & Weaknesses
Table 62. Foundation Medicine Basic Information, Manufacturing Base and Competitors
Table 63. Foundation Medicine Major Business
Table 64. Foundation Medicine Molecular Pathology Services Product and Services
Table 65. Foundation Medicine Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Foundation Medicine Recent Developments/Updates
Table 67. Foundation Medicine Competitive Strengths & Weaknesses
Table 68. Caris Life Sciences Basic Information, Manufacturing Base and Competitors
Table 69. Caris Life Sciences Major Business
Table 70. Caris Life Sciences Molecular Pathology Services Product and Services
Table 71. Caris Life Sciences Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Caris Life Sciences Recent Developments/Updates
Table 73. Caris Life Sciences Competitive Strengths & Weaknesses
Table 74. Tempus Basic Information, Manufacturing Base and Competitors
Table 75. Tempus Major Business
Table 76. Tempus Molecular Pathology Services Product and Services
Table 77. Tempus Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Tempus Recent Developments/Updates
Table 79. Tempus Competitive Strengths & Weaknesses
Table 80. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 81. Guardant Health Major Business
Table 82. Guardant Health Molecular Pathology Services Product and Services
Table 83. Guardant Health Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Guardant Health Recent Developments/Updates
Table 85. Guardant Health Competitive Strengths & Weaknesses
Table 86. Exact Sciences Basic Information, Manufacturing Base and Competitors
Table 87. Exact Sciences Major Business
Table 88. Exact Sciences Molecular Pathology Services Product and Services
Table 89. Exact Sciences Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Exact Sciences Recent Developments/Updates
Table 91. Exact Sciences Competitive Strengths & Weaknesses
Table 92. Eurofins Basic Information, Manufacturing Base and Competitors
Table 93. Eurofins Major Business
Table 94. Eurofins Molecular Pathology Services Product and Services
Table 95. Eurofins Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Eurofins Recent Developments/Updates
Table 97. Eurofins Competitive Strengths & Weaknesses
Table 98. Unilabs Basic Information, Manufacturing Base and Competitors
Table 99. Unilabs Major Business
Table 100. Unilabs Molecular Pathology Services Product and Services
Table 101. Unilabs Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Unilabs Recent Developments/Updates
Table 103. Unilabs Competitive Strengths & Weaknesses
Table 104. Global Key Players of Molecular Pathology Services Upstream (Raw Materials)
Table 105. Global Molecular Pathology Services Typical Customers
Table 1. World Molecular Pathology Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Molecular Pathology Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Molecular Pathology Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Molecular Pathology Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Molecular Pathology Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Molecular Pathology Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Molecular Pathology Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Molecular Pathology Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Molecular Pathology Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Molecular Pathology Services Players in 2025
Table 12. World Molecular Pathology Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Molecular Pathology Services Company Evaluation Quadrant
Table 14. Head Office of Key Molecular Pathology Services Players
Table 15. Molecular Pathology Services Market: Company Product Type Footprint
Table 16. Molecular Pathology Services Market: Company Product Application Footprint
Table 17. Molecular Pathology Services Mergers & Acquisitions Activity
Table 18. United States VS China Molecular Pathology Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Molecular Pathology Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Molecular Pathology Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Molecular Pathology Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Molecular Pathology Services Revenue Market Share (2021-2026)
Table 23. China Based Molecular Pathology Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Molecular Pathology Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Molecular Pathology Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Molecular Pathology Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Molecular Pathology Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Molecular Pathology Services Revenue Market Share (2021-2026)
Table 29. World Molecular Pathology Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Molecular Pathology Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Molecular Pathology Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Molecular Pathology Services Market Size by Service Content, (USD Million), 2021 & 2025 & 2032
Table 33. World Molecular Pathology Services Market Size Value by Service Content (2021-2026) & (USD Million)
Table 34. World Molecular Pathology Services Market Size by Service Content (2027-2032) & (USD Million)
Table 35. World Molecular Pathology Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Molecular Pathology Services Market Size by Application (2021-2026) & (USD Million)
Table 37. World Molecular Pathology Services Market Size by Application (2027-2032) & (USD Million)
Table 38. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 39. Quest Diagnostics Major Business
Table 40. Quest Diagnostics Molecular Pathology Services Product and Services
Table 41. Quest Diagnostics Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Quest Diagnostics Recent Developments/Updates
Table 43. Quest Diagnostics Competitive Strengths & Weaknesses
Table 44. Labcorp Basic Information, Manufacturing Base and Competitors
Table 45. Labcorp Major Business
Table 46. Labcorp Molecular Pathology Services Product and Services
Table 47. Labcorp Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Labcorp Recent Developments/Updates
Table 49. Labcorp Competitive Strengths & Weaknesses
Table 50. Sonic Healthcare Basic Information, Manufacturing Base and Competitors
Table 51. Sonic Healthcare Major Business
Table 52. Sonic Healthcare Molecular Pathology Services Product and Services
Table 53. Sonic Healthcare Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Sonic Healthcare Recent Developments/Updates
Table 55. Sonic Healthcare Competitive Strengths & Weaknesses
Table 56. NeoGenomics Basic Information, Manufacturing Base and Competitors
Table 57. NeoGenomics Major Business
Table 58. NeoGenomics Molecular Pathology Services Product and Services
Table 59. NeoGenomics Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. NeoGenomics Recent Developments/Updates
Table 61. NeoGenomics Competitive Strengths & Weaknesses
Table 62. Foundation Medicine Basic Information, Manufacturing Base and Competitors
Table 63. Foundation Medicine Major Business
Table 64. Foundation Medicine Molecular Pathology Services Product and Services
Table 65. Foundation Medicine Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Foundation Medicine Recent Developments/Updates
Table 67. Foundation Medicine Competitive Strengths & Weaknesses
Table 68. Caris Life Sciences Basic Information, Manufacturing Base and Competitors
Table 69. Caris Life Sciences Major Business
Table 70. Caris Life Sciences Molecular Pathology Services Product and Services
Table 71. Caris Life Sciences Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Caris Life Sciences Recent Developments/Updates
Table 73. Caris Life Sciences Competitive Strengths & Weaknesses
Table 74. Tempus Basic Information, Manufacturing Base and Competitors
Table 75. Tempus Major Business
Table 76. Tempus Molecular Pathology Services Product and Services
Table 77. Tempus Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Tempus Recent Developments/Updates
Table 79. Tempus Competitive Strengths & Weaknesses
Table 80. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 81. Guardant Health Major Business
Table 82. Guardant Health Molecular Pathology Services Product and Services
Table 83. Guardant Health Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Guardant Health Recent Developments/Updates
Table 85. Guardant Health Competitive Strengths & Weaknesses
Table 86. Exact Sciences Basic Information, Manufacturing Base and Competitors
Table 87. Exact Sciences Major Business
Table 88. Exact Sciences Molecular Pathology Services Product and Services
Table 89. Exact Sciences Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Exact Sciences Recent Developments/Updates
Table 91. Exact Sciences Competitive Strengths & Weaknesses
Table 92. Eurofins Basic Information, Manufacturing Base and Competitors
Table 93. Eurofins Major Business
Table 94. Eurofins Molecular Pathology Services Product and Services
Table 95. Eurofins Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Eurofins Recent Developments/Updates
Table 97. Eurofins Competitive Strengths & Weaknesses
Table 98. Unilabs Basic Information, Manufacturing Base and Competitors
Table 99. Unilabs Major Business
Table 100. Unilabs Molecular Pathology Services Product and Services
Table 101. Unilabs Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Unilabs Recent Developments/Updates
Table 103. Unilabs Competitive Strengths & Weaknesses
Table 104. Global Key Players of Molecular Pathology Services Upstream (Raw Materials)
Table 105. Global Molecular Pathology Services Typical Customers
LIST OF FIGURES
Figure 1. Molecular Pathology Services Picture
Figure 2. World Molecular Pathology Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Molecular Pathology Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Molecular Pathology Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Molecular Pathology Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Molecular Pathology Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Molecular Pathology Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Molecular Pathology Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Molecular Pathology Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Molecular Pathology Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Molecular Pathology Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Molecular Pathology Services Revenue (2021-2032) & (USD Million)
Figure 13. Molecular Pathology Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Molecular Pathology Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Molecular Pathology Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Molecular Pathology Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Molecular Pathology Services Markets in 2025
Figure 27. United States VS China: Molecular Pathology Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Molecular Pathology Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Molecular Pathology Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Molecular Pathology Services Market Size Market Share by Type in 2025
Figure 31. Solid Tumor Molecular Pathology Services
Figure 32. Hematologic Malignancy Molecular Pathology Services
Figure 33. Hereditary Disease Molecular Pathology Services
Figure 34. Infectious Disease Molecular Testing Services
Figure 35. Rare Disease Molecular Pathology Services
Figure 36. Others
Figure 37. World Molecular Pathology Services Market Size Market Share by Type (2021-2032)
Figure 38. World Molecular Pathology Services Market Size by Service Content, (USD Million), 2021 & 2025 & 2032
Figure 39. World Molecular Pathology Services Market Size Market Share by Service Content in 2025
Figure 40. Single-Gene Testing Services
Figure 41. Targeted Panel Testing Services
Figure 42. Comprehensive Genomic Profiling Services
Figure 43. Companion Diagnostic Support Services
Figure 44. Pathology Consultation and Interpretation Services
Figure 45. Others
Figure 46. World Molecular Pathology Services Market Size Market Share by Service Content (2021-2032)
Figure 47. World Molecular Pathology Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Molecular Pathology Services Market Size Market Share by Application in 2025
Figure 49. Hospitals and Medical Centers
Figure 50. Independent Clinical Laboratories
Figure 51. Academic and Research Institutes
Figure 52. Biopharmaceutical Companies
Figure 53. Others
Figure 54. World Molecular Pathology Services Market Size Market Share by Application (2021-2032)
Figure 55. Molecular Pathology Services Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Molecular Pathology Services Picture
Figure 2. World Molecular Pathology Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Molecular Pathology Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Molecular Pathology Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Molecular Pathology Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Molecular Pathology Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Molecular Pathology Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Molecular Pathology Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Molecular Pathology Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Molecular Pathology Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Molecular Pathology Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Molecular Pathology Services Revenue (2021-2032) & (USD Million)
Figure 13. Molecular Pathology Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Molecular Pathology Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Molecular Pathology Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Molecular Pathology Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Molecular Pathology Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Molecular Pathology Services Markets in 2025
Figure 27. United States VS China: Molecular Pathology Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Molecular Pathology Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Molecular Pathology Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Molecular Pathology Services Market Size Market Share by Type in 2025
Figure 31. Solid Tumor Molecular Pathology Services
Figure 32. Hematologic Malignancy Molecular Pathology Services
Figure 33. Hereditary Disease Molecular Pathology Services
Figure 34. Infectious Disease Molecular Testing Services
Figure 35. Rare Disease Molecular Pathology Services
Figure 36. Others
Figure 37. World Molecular Pathology Services Market Size Market Share by Type (2021-2032)
Figure 38. World Molecular Pathology Services Market Size by Service Content, (USD Million), 2021 & 2025 & 2032
Figure 39. World Molecular Pathology Services Market Size Market Share by Service Content in 2025
Figure 40. Single-Gene Testing Services
Figure 41. Targeted Panel Testing Services
Figure 42. Comprehensive Genomic Profiling Services
Figure 43. Companion Diagnostic Support Services
Figure 44. Pathology Consultation and Interpretation Services
Figure 45. Others
Figure 46. World Molecular Pathology Services Market Size Market Share by Service Content (2021-2032)
Figure 47. World Molecular Pathology Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Molecular Pathology Services Market Size Market Share by Application in 2025
Figure 49. Hospitals and Medical Centers
Figure 50. Independent Clinical Laboratories
Figure 51. Academic and Research Institutes
Figure 52. Biopharmaceutical Companies
Figure 53. Others
Figure 54. World Molecular Pathology Services Market Size Market Share by Application (2021-2032)
Figure 55. Molecular Pathology Services Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
